Correlation Between Edgewise Therapeutics and Aptevo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Aptevo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Aptevo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Aptevo Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Aptevo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Aptevo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Aptevo Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Aptevo Therapeutics
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Edgewise and Aptevo is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Aptevo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptevo Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Aptevo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptevo Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Aptevo Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Aptevo Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.59 times more return on investment than Aptevo Therapeutics. However, Edgewise Therapeutics is 1.7 times less risky than Aptevo Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Aptevo Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 917.00 in Edgewise Therapeutics on August 31, 2024 and sell it today you would earn a total of 2,383 from holding Edgewise Therapeutics or generate 259.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Aptevo Therapeutics
Performance |
| Timeline |
| Edgewise Therapeutics |
| Aptevo Therapeutics |
Edgewise Therapeutics and Aptevo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Aptevo Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Aptevo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Aptevo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptevo Therapeutics will offset losses from the drop in Aptevo Therapeutics' long position.| Edgewise Therapeutics vs. Cue Biopharma | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx | Edgewise Therapeutics vs. Molecular Partners AG |
| Aptevo Therapeutics vs. Kronos Bio | Aptevo Therapeutics vs. Cyclerion Therapeutics | Aptevo Therapeutics vs. Larimar Therapeutics | Aptevo Therapeutics vs. Addex Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |